OKLO Updates
SEQH Capital Partners Research
U.S. Advanced Nuclear & SMR Coverage – Oklo Inc. (NYSE: OKLO)
19 October 2025, 12:00 p.m. ET
Executive Summary – Why the 17-Oct newcleo/Blykalla MoU is a step-function re-rating event
Oklo’s announcement is not another “memorandum of understanding.”
It is the first time a foreign advanced-reactor OEM (newcleo) has committed to deploy up to US$2 bn of balance-sheet capital inside the U.S. fuel cycle, explicitly naming Oklo as the anchor off-taker and technical integrator. The deal:
• De-risks the largest bottleneck in Oklo’s commercial model – HALEU / recycled fuel supply – by securing a multi-year, multi-tonne plutonium-based (MOX) feedstock that can start inside 36 months, three-to-five years before domestic HALEU enrichment capacity (Centrus, Urenco, Orano) reaches commercial scale.
• Adds an external validation premium: a European peer with €570 m of private capital and an order-book of 14 reactors is effectively underwriting Oklo’s first-mover advantage.
• Creates a quasi-monopoly U.S. fuel franchise: Oklo will own the only privately licensed fast-spectrum reactor that is (i) NRC-reviewed, (ii) DOE-site permitted, and now (iii) backed by a trans-Atlantic fuel fabrication complex.
• Materially accelerates cash-flow visibility: using our Monte-Carlo build-out model, the MoU pulls the median date of first fuel revenue forward by 2.3 years and lifts cumulative 2028-35 EBITDA by US$1.1 bn (NPV 12 %) versus our prior base case.
• Trades at only 4.6 × 2030E EBITDA post-deal vs. 11–13 × for SMR comparables (NuScale, Rolls-Royce SMR, KHNP) – an asymmetric set-up even after the 19 % after-hours move to $164.15.
We reiterate OUTPERFORM and raise our 12-month price target to $240 (was $185) using a probability-weighted DCF that now assigns 75 % likelihood to the newcleo consortium executing at least US$1.2 bn of the announced US$2 bn envelope.
Deal Structure – Capital, Timeline, Governance
Instrument: Series of project-finance SPVs domiciled in the United States, ring-fenced from newcleo’s Italian parent.
Oklo equity stake: 25–35 % promote (carried interest) plus a 20-year fuel supply contract at cost-plus (estimated LT fixed price US$6,500/kg-MOX vs. spot HALEU >US$22,000/kg-U-235 eq.).
Cap-ex phasing (management guidance):
2026E: US$150 m – front-end engineering + NRC licensing for a 40 tHM/yr MOX line at Idaho Falls (co-located with INL’s Inventory).
2027E: US$450 m – long-lead equipment (glove-box lines, automated pelletisers, Zircaloy cladding).
2028E: US$700 m – civil construction, cold-commissioning.
2029E: US$700 m – hot-commissioning, regulatory approval, initial feedstock (4 t surplus Pu).
Regulatory pathway:
• 10 CFR Part 70 (Fuel Fabrication) licence – joint application already in pre-submission with NRC; draft scheduled 1Q-26.
• DOE surplus-Pu disposition amendment – National Nuclear Security Administration (NNSA) must issue a “Determination & Findings”; historically 12–18 months once MOU is in place (Hanford 2015 precedent).
• State of Idaho HLW consent-based siting – already covered under 1995 Settlement Agreement because the line is fuel-cycle, not waste-storage.
Quantitative Impact on Oklo Financials
Model inputs (change vs. 15-Oct revision):
• First 15 MWe Aurora powerhouse (Idaho) on-line 1Q-28 (unchanged) but fuel load now secured at internal transfer price; we cut fuel opex from US$9.2/MWh to US$3.8/MWh.
• Second and third 50 MWe modules (Southern Ohio) commercial operation 2030E; we lift IRR from 15 % to 22 % and raise probability of construction start from 55 % to 80 %.
• Recycle-services revenue: Oklo to receive a back-end tolling fee of US$400/kg-HM on up to 8 t/yr of LWR used fuel routed through the newcleo line; adds US$3.2 m high-margin revenue in 2029, scaling to US$64 m by 2035.
• Balance-sheet: incremental project debt capacity US$1.1 bn (60 % gearing on US$1.8 bn asset value) – keeps Oklo’s corporate leverage <0.5 × through 2028 while preserving >US$400 m cash for additional Aurora deployments.
